JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 18, 2009; DOI: 10.1124/jpet.108.145953


0022-3565/09/3293-875-881$20.00
JPET 329:875-881, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.145953v1
329/3/875    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Tykocki, N. R.
Right arrow Articles by Watts, S. W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tykocki, N. R.
Right arrow Articles by Watts, S. W.

CARDIOVASCULAR

Endothelin ETB Receptors in Arteries and Veins: Multiple Actions in the Vein

Nathan R. Tykocki, Cheryl E. Gariepy, and Stephanie W. Watts

Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan (N.R.T., S.W.W.); and Department of Pediatrics and Communicable Disease, University of Michigan, Ann Arbor, Michigan (C.E.G.)

Endothelin receptors (ETA and ETB) mediate responses to ET-1. ETB receptor function seems to differ between a similarly sized arterial and venous pair, the rat vena cava (RVC) and rat thoracic aorta (RA). ETB receptors mediate RVC contraction directly, but it is unclear whether ETB receptors mediate contraction in RA. Because of these apparent differences in ETB receptor-mediated vascular contraction, we hypothesize that relaxant ETB-receptor mechanisms in RVC would be different from those in RA. RA and RVC rings were isolated from rats for measurement of isometric contraction. When contracted with prostaglandin F-2{alpha} (PGF-2{alpha}) (20 µM), the ETB receptor agonist sarafotoxin-6c (S6c) (100 nM) significantly relaxed RA and RVC. N{omega}-Nitro-L-arginine (LNNA) (100 µM) or endothelial denudation abolished relaxation to S6c in RA. By contrast, S6c-induced relaxation of RVC was attenuated but not abolished by LNNA and endothelial denudation. RVC (PGF-2{alpha}-contracted) relaxed to low concentrations of ET-1, whereas under the same conditions RA responded with contraction. ET-1-induced relaxation in RA was observed only with ETA receptor blockade. Vessels from dopamine-β-hydroxylase-ETB transgenic rats, which lack functional ETB receptors in the vasculature, were also used. RVC (PGF-2{alpha}-contracted) from these rats did not relax to ET-1. Thus, although both RA and RVC possess endothelial relaxant ETB receptors, RA and RVC differ in that relaxant ETB receptors may also be present in smooth muscle of RVC. Moreover, the mechanisms of endothelial cell ETB receptor-mediated relaxation in RA and RVC are not the same.


Received for publication September 26, 2008
Accepted March 16, 2009.

Address correspondence to: Nathan R. Tykocki, Department of Pharmacology and Toxicology, Michigan State University, B445 Life Sciences Bldg., East Lansing, MI 48824. E-mail: tykockin{at}msu.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics.